Swiss study to track new kidney drug in 50 patients
Disease control
Not yet recruiting
This study will follow 50 adults with IgA nephropathy who are taking sparsentan. Researchers want to see how the drug affects protein in the urine (albuminuria), a key sign of kidney damage. The study is observational, meaning it just watches what happens in real-world use, witho…
Sponsor: Waid City Hospital, Zurich • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC